Either way, future studies that aim to extend GLP1 function and/or mimic its function through the use of GLP1 receptor agonists, such as exenatide, may offer promise in relation to increasing satiety and regulating energy homeostasis and, therefore, treating obesity. This evidence concerns the gene GLP1R and obesity disorder.